Heron Therapeutics Inc.
Organization details
- Legal name
- Heron Therapeutics Inc.
- Former names
- AP Pharma Inc Advanced Polymer Systems Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Diego
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HRTX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0000818033
- EIN
- 94-2875566
Board of directors
-
Adam Morgan · DirectorSince 2023
-
Barry D. Quart · Director · Chief Executive OfficerSince 2023
-
Craig A. Collard · Director · Chief Executive OfficerSince 2023
-
Craig A. Johnson · DirectorSince 2024
-
Kevin Kotler · DirectorSince 2023
-
Kimberly Manhard · Director · EVP, Drug DevelopmentSince 2023
-
Michael Kaseta · DirectorSince 2024
-
Sharmila Dissanaike · DirectorSince 2024
-
Susan Rodriguez · DirectorSince 2024
-
Thomas Cusack · DirectorSince 2025
-
Waage Christian · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 6, 2023. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.9%
-
98.0%
-
98.0%
-
98.6%
-
98.7%
-
99.1%
Board connections
3 of this board's directors also sit on 4 other boards. 4 are in the same sector.
-
Aurinia Pharmaceuticals Inc Same sectorvia Craig A. Johnson
-
Connect Biopharma Holdings Limited Same sectorvia Barry D. Quart
-
Inhibrx Biosciences Inc. Same sectorvia Kimberly Manhard
-
Kiniksa Pharmaceuticals International plc Same sectorvia Barry D. Quart
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 6, 2026 | Hensley Mark Earl Officer (Chief Operating Officer) | Option exercise | +31,250 | — | — |
| Nov 6, 2026 | Hensley Mark Earl Officer (Chief Operating Officer) | Shares withheld for tax | −8,889 | $0.29 | $2,578 |
| Oct 31, 2026 | Craig A. Collard Director, Officer (Chief Executive Officer) | Option exercise | +34,788 | — | — |
| Oct 31, 2026 | Duarte Ira Officer (EVP, Chief Financial Officer) | Option exercise | +11,695 | — | — |
| Oct 31, 2026 | William P. Forbes Officer (EVP, Chief Development Officer) | Option exercise | +11,695 | — | — |
| Oct 31, 2026 | Craig A. Collard Director, Officer (Chief Executive Officer) | Shares withheld for tax | −8,471 | $0.28 | $2,372 |
| Oct 31, 2026 | Duarte Ira Officer (EVP, Chief Financial Officer) | Shares withheld for tax | −3,327 | $0.28 | $932 |
| Oct 31, 2026 | William P. Forbes Officer (EVP, Chief Development Officer) | Shares withheld for tax | −3,327 | $0.28 | $932 |
| Oct 30, 2026 | Craig A. Collard Director, Officer (Chief Executive Officer) | Option exercise | +50,021 | — | — |
| Oct 30, 2026 | Duarte Ira Officer (EVP, Chief Financial Officer) | Option exercise | +13,535 | — | — |
| Oct 30, 2026 | William P. Forbes Officer (EVP, Chief Development Officer) | Option exercise | +11,770 | — | — |
| Oct 30, 2026 | Hensley Mark Earl Officer (Chief Operating Officer) | Option exercise | +11,770 | — | — |
| Oct 30, 2026 | Craig A. Collard Director, Officer (Chief Executive Officer) | Shares withheld for tax | −12,181 | $0.28 | $3,411 |
| Oct 30, 2026 | Duarte Ira Officer (EVP, Chief Financial Officer) | Shares withheld for tax | −3,850 | $0.28 | $1,078 |
| Oct 30, 2026 | William P. Forbes Officer (EVP, Chief Development Officer) | Shares withheld for tax | −3,349 | $0.28 | $938 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Heron Therapeutics Inc.
Who is the CEO of Heron Therapeutics Inc.?
Barry D. Quart is Heron Therapeutics Inc.'s Chief Executive Officer.
How many directors are on Heron Therapeutics Inc.'s board?
Heron Therapeutics Inc.'s board has 11 directors: Adam Morgan, Barry D. Quart, Craig A. Collard, Craig A. Johnson, Kevin Kotler, Kimberly Manhard, Michael Kaseta, Sharmila Dissanaike, Susan Rodriguez, Thomas Cusack and 1 other.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="heron-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.